Mediterraneibacter massiliensis

Information

Microbe Identification

Mediterraneibacter massiliensis

Microbe id: PMDBM2020856
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Mediterraneibacter massiliensis [1720300]
Taxonomy Genus: Mediterraneibacter [2316020]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Mediterraneibacter massiliensis

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clustern.a.Fatty acids-unassignedPMID: 36782070
Unclassified gene clustern.a.Others HGD unassignedPMID: 36782070
Unclassified gene clusterAmino acidsTPP AA metabolismPMID: 36782070
PorA C. sporogenesCholine/proline/tryptophan/Tyr/Phe/leucine/valine / n.a.PorA,OD unknownPMID: 31831639 / PMID: 36782070
Propanediol degradation S. entericaGlycerol / ethanolamineGR eut-pdu-relatedPMID: 27242734 / PMID: 20234377
Ech complex T. phaeumEnergy-capturing-relatedEch complexPMID: 30850546
Proline to aminovalerate C. sticklandiiProlineProline to aminovaleratePMID: 20937090
PFOR II pathway B. thetaiotaomicronPyruvatePFOR II pathwayPMID: 32301184
Hydroxy-L-proline2proline C. difficileHydroxy-L-prolineHydroxy-L-proline to prolinePMID: 32180548
Pyruvate to acetate-formate E. coliPyruvatePyruvate to acetate-formatePMID: 20622067
Rnf complex C. sporogenesEnergy-capturing-related / succinateRnf complex,succinate to propionatePMID: 23269825 / PMID: 24553467

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Mediterraneibacter massiliensis


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.RRE-containingPMID: 34019648
Unclassified gene clustern.a.RanthipeptidePMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Mediterraneibacter massiliensis distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Mediterraneibacter massiliensis in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Mediterraneibacter massiliensis

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA648014🔗4.1802307224253616S
Kidney Failure, Chronic PRJEB65297🔗4.29145147081197mNGS
Kidney Failure, Chronic PRJNA449784🔗4.37677264577677mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.6308845757099mNGS
Diarrhea PRJEB14038🔗-3.79945157292495mNGS
Rett Syndrome PRJNA687633🔗4.2027170189520816S
Colorectal Neoplasms PRJNA888860🔗-2.89911609229857mNGS
Colorectal Neoplasms PRJEB46665🔗4.2069293956116S
Colorectal Neoplasms PRJNA1050885🔗4.31695784459433mNGS
Colorectal Neoplasms PRJNA1138893🔗4.43682278324553mNGS
Respiratory Syncytial Virus Infections PRJNA579491🔗4.4081919649982316S
Hepatitis, Autoimmune PRJNA556801🔗3.6368990267642216S
Colitis, Ulcerative PRJNA804422🔗4.217841059795416S
Spinal Cord Injuries PRJNA861246🔗4.1232469125849316S
Hepatitis B, Chronic PRJNA872871🔗4.0317684460158316S
Carcinoma, Renal Cell PRJNA842560🔗3.9051473016882316S
Carcinoma, Hepatocellular PRJNA872871🔗4.3714518591215316S
Helicobacter Infections PRJDB10599🔗-3.9075556095975216S
Narcolepsy PRJEB38491🔗3.5104479145073216S
Hepatolenticular Degeneration PRJNA1038771🔗4.369542473840816S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.7248934650747116S
Schizophrenia PRJNA1135717🔗4.22846765247715mNGS
Emergence Delirium PRJNA797529🔗4.3530842394553616S
Hidradenitis Suppurativa PRJEB43835🔗4.0247917233333216S
Leukemia, Myeloid, Acute PRJNA813705🔗3.98533201602834mNGS
Crohn Disease PRJNA820056🔗-3.7944265970554316S
Crohn Disease PRJNA993675🔗4.14405122643078mNGS
Crohn Disease PRJNA917086🔗4.8285508640049516S
Moyamoya Disease PRJNA917033🔗4.0533828394424916S
Multiple System Atrophy PRJNA532538🔗-4.72049242611732mNGS
Appendicitis PRJDB8606🔗-4.37123917445316S
Diabetic Retinopathy PRJNA646010🔗-4.2260200473178116S
Dermatitis, Atopic PRJEB45443🔗4.06406936341027mNGS
Arthritis, Rheumatoid PRJNA896336🔗3.98736250756677mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗3.45940316151719mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗3.57904941024302mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗4.214961427819116S
Hepatitis C PRJNA328966🔗-3.6050013692159216S
Graves Ophthalmopathy PRJNA1089481🔗-4.0762537355005816S
Irritable Bowel Syndrome PRJNA682378🔗-3.4331704901032916S
Irritable Bowel Syndrome PRJEB37924🔗3.99329006935674mNGS
Clostridium Infections PRJNA648321🔗4.73656676151094mNGS
Liver Cirrhosis PRJNA872871🔗4.0285904766603316S
Liver Cirrhosis PRJNA861246🔗4.1523260052897316S
Obesity PRJNA1125836🔗4.25276244056261mNGS
Diabetes Mellitus PRJNA400325🔗4.3609014951921616S
HIV Infections PRJNA810567🔗-4.6057561939081616S
Autism Spectrum Disorder PRJNA917543🔗3.6579633990091916S
Retinal Artery Occlusion PRJEB24557🔗-2.95291795761016mNGS
Inflammatory Bowel Diseases PRJNA511372🔗-4.81288996514491mNGS
Biliary Atresia PRJNA730640🔗-3.56421300849884mNGS
Renal Insufficiency, Chronic PRJNA562327🔗4.3158275045116416S
Renal Insufficiency, Chronic PRJEB65297🔗4.45045834315484mNGS
Multiple Sclerosis PRJEB28543🔗4.14911546375479mNGS
Multiple Sclerosis PRJNA721421🔗4.4318533016747116S
Fibromyalgia PRJEB80379🔗-3.94490044081911mNGS
Breast Neoplasms PRJNA658160🔗3.4214077096372816S
COVID-19 PRJNA678695🔗-4.6749122146120616S
COVID-19 PRJNA769052🔗4.0153737834556516S
COVID-19 PRJNA907010🔗4.3522718431168716S
COVID-19 PRJDB13214🔗4.71621498513971mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Mediterraneibacter massiliensis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Mediterraneibacter massiliensis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Mediterraneibacter massiliensis

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Mediterraneibacter_massiliensis_DSM_100837 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Mediterraneibacter massiliensis


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Mediterraneibacter massiliensis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Mediterraneibacter massiliensis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Mediterraneibacter massiliensis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Mediterraneibacter massiliensis

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found!

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Mediterraneibacter massiliensis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Mediterraneibacter massiliensis


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Mediterraneibacter massiliensis


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?